Trichomonas vaginalis
General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.
Overview
A sexually transmitted protozoan parasite and the most common non-viral sexually transmitted infection.
Infections
Trichomoniasis: vaginitis, urethritis; associated with preterm birth and HIV acquisition.
Signs and symptoms
Frothy yellow-green discharge, odor, itching, dysuria; often no symptoms, especially in men.
Antibiotic and antimicrobial resistance
Metronidazole resistance occurs at low levels.
Treatment considerations
Metronidazole per CDC guidelines (a multi-dose course is recommended for women); treat partners.
Infection control and public health
Partner treatment; retesting is recommended.

Sources
- CDC. Trichomoniasis (STI Treatment Guidelines).
- CDC DPDx. Trichomoniasis.
Sources accessed November 2026. Links open external sites that InnovexLab does not control.
Medical disclaimer
This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.
Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.